Live Breaking News & Updates on Resaphene Suisse Ag

Stay updated with breaking news from Resaphene suisse ag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Resaphene Suisse AG Announcements | Resaphene Suisse AG: FDA approval process continues

Investegate announcements from Resaphene Suisse AG, FDA approval process continues ....

United States , Switzerland General , Thomas Rauterkus , Elon Musk , Anke Rauterkus , Research Technology , Resaphene Suisse , Chief Medical Officer Thomas Rauterkus , Chief Executive Officer , Press Release , Investegate Announcements , Investegate Company Announcements , Resaphene Suisse Ag , Egulatory News Service , Egulatory News Service And Regulatory ,

Resaphene Suisse AG: FDA approval process for tinnitus therapy tinniwell continues

13.07.2022 - EQS-Media / 13.07.2022 / 12:42 Roggwil, July 13, 2022 - Due to the COVID pandemic, work for the FDA approval of the tinniwell was stopped at the beginning of 2021. This has now been resumed and Chief Medical Officer Thomas Rauterkus has been . ....

United States , Switzerland General , Thomas Rauterkus , Elon Musk , Anke Rauterkus , Chief Medical Officer Thomas , Resaphene Suisse , Chief Executive Officer , Resaphene Suisse Ag ,